Giercksky K E
Scand J Haematol. 1977 Mar;18(3):219-25. doi: 10.1111/j.1600-0609.1977.tb02333.x.
Rat blood platelets were treated with phospholipase C in vitro or phospholipase C was injected i.v. to rats. In both cases its effect on the functions of the platelets in vivo has been studied. No change was found in primary bleeding time or in platelet survival. Treatment with phospholipase C gave a moderate reduction of ADP-induced platelet aggregation in the pulmonary circulation whereas the aggregation induced by thrombin was unchanged. Iv. injection of phospholipase C caused a rapid, very moderate and transient increase of 51Cr-activity in the lungs without concomitant overt respiratory distress. A moderate increase in 51Cr-activity was noted in liver and kidney 24 and 48 h after injection of phospholipase C. This may be caused by a slightly increased leakage of 51Cr-labelled material from the platelets during exposure to phospholipase C.
用磷脂酶C在体外处理大鼠血小板,或将磷脂酶C静脉注射到大鼠体内。在这两种情况下,均研究了其对体内血小板功能的影响。未发现初发出血时间或血小板存活时间有变化。用磷脂酶C处理可使肺循环中ADP诱导的血小板聚集适度降低,而凝血酶诱导的聚集则无变化。静脉注射磷脂酶C导致肺部51Cr活性迅速、非常适度且短暂升高,同时未伴有明显的呼吸窘迫。注射磷脂酶C后24小时和48小时,肝脏和肾脏中的51Cr活性出现适度升高。这可能是由于在暴露于磷脂酶C期间,51Cr标记物质从血小板中的泄漏略有增加所致。